Paper9736552
Effect of food on the bioavailability of stavudine in subjects with human immunodeficiency virus infection.
Kaul S and 4 others. Antimicrob Agents Chemother, 1998. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Effect of food on the bioavailability of stavudine in subjects with human immunodeficiency virus infection. Papers, record 9736552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9736552
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of food on the bioavailability of stavudine in subjects with human immunodeficiency virus infection.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-HIV Agents | Major topic |
| HIV Infections | Major topic |
| Stavudine | Major topic |
| Adolescent | |
| Adult | |
| Biological Availability | |
| Cross-Over Studies | |
| Female | |
| Food | |
| Humans | |
| Male |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8366182 | Effect of time of food administration on the bioavailability of didanosine from a chewable tablet formulation. | J Clin Pharmacol | 1993 | https://conductscience.org/library/papers/8366182 | PubMed |
| 2 | 8239589 | In vitro and in vivo disposition and metabolism of 3'-deoxy-2',3'-didehydrothymidine. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8239589 | PubMed |
| 3 | 7861015 | Biologic effects and safety of stavudine: overview of phase I and II clinical trials. | J Infect Dis | 1995 | https://conductscience.org/library/papers/7861015 | PubMed |
| 4 | 2852679 | Pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS and related disorders. | J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/2852679 | PubMed |
| 5 | 7856987 | Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working Group. | Ann Intern Med | 1995 | https://conductscience.org/library/papers/7856987 | PubMed |
| 6 | 1389940 | The effect of a protein meal on zidovudine pharmacokinetics in HIV-infected patients. | Br J Clin Pharmacol | 1992 | https://conductscience.org/library/papers/1389940 | PubMed |
| 7 | 7780046 | Dose proportionality of stavudine in HIV seropositive asymptomatic subjects: application to bioequivalence assessment of various capsule formulations. | Biopharm Drug Dispos | 1995 | https://conductscience.org/library/papers/7780046 | PubMed |
| 8 | 2111751 | Pharmacokinetics of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in patients with severe human immunodeficiency virus infection. | Clin Pharmacol Ther | 1990 | https://conductscience.org/library/papers/2111751 | PubMed |
| 9 | 7630678 | A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection. | Pediatrics | 1995 | https://conductscience.org/library/papers/7630678 | PubMed |
| 10 | 8093363 | 2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial. | J Infect Dis | 1993 | https://conductscience.org/library/papers/8093363 | PubMed |
| 11 | 2060570 | Decreased and variable systemic availability of zidovudine in patients with AIDS if administered with a meal. | Eur J Clin Pharmacol | 1991 | https://conductscience.org/library/papers/2060570 | PubMed |
| 12 | 7963708 | Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapy. | J Infect Dis | 1994 | https://conductscience.org/library/papers/7963708 | PubMed |
| 13 | 8709213 | Human immunodeficiency virus type 1 drug susceptibility during zidovudine (AZT) monotherapy compared with AZT plus 2',3'-dideoxyinosine or AZT plus 2',3'-dideoxycytidine combination therapy. The protocol 34,225-02 Collaborative Group. | J Virol | 1996 | https://conductscience.org/library/papers/8709213 | PubMed |
| 14 | 8933418 | Specific radioimmunoassays for the measurement of stavudine in human plasma and urine. | J Pharm Biomed Anal | 1996 | https://conductscience.org/library/papers/8933418 | PubMed |
| 15 | 9758571 | Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infection. | Ann Intern Med | 1998 | https://conductscience.org/library/papers/9758571 | PubMed |
| 16 | 3165603 | Pharmacokinetics and bioavailability of zidovudine in humans. | Am J Med | 1988 | https://conductscience.org/library/papers/3165603 | PubMed |
| 17 | 8390811 | Pharmacokinetics of the anti-human immunodeficiency virus nucleoside analog stavudine in cynomolgus monkeys. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8390811 | PubMed |
| 18 | 1323615 | Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complex. | J Infect Dis | 1992 | https://conductscience.org/library/papers/1323615 | PubMed |
| 19 | 2350441 | Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat meal. | AIDS | 1990 | https://conductscience.org/library/papers/2350441 | PubMed |
| 20 | 7861017 | Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089. | J Infect Dis | 1995 | https://conductscience.org/library/papers/7861017 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36318429 | Interactions of Antiretroviral Drugs with Food, Beverages, Dietary Supplements, and Alcohol: A Systematic Review and Meta-analyses. | AIDS Behav | 2023 | https://conductscience.org/library/papers/36318429 | PubMed |
| 25697412 | Effect of reducing the paediatric stavudine dose by half: a physiologically-based pharmacokinetic model. | Int J Antimicrob Agents | 2015 | https://conductscience.org/library/papers/25697412 | PubMed |
| 19942751 | Pharmacokinetics of lamivudine & stavudine in generic fixed-dose combinations in HIV-1 infected adults in India. | Indian J Med Res | 2009 | https://conductscience.org/library/papers/19942751 | PubMed |
| 10595868 | Stavudine: an update of its use in the treatment of HIV infection. | Drugs | 1999 | https://conductscience.org/library/papers/10595868 | PubMed |
| 10511919 | Effects of food on clinical pharmacokinetics. | Clin Pharmacokinet | 1999 | https://conductscience.org/library/papers/10511919 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9736552
GET https://conductscience.org/api/papers/v1/9736552/references?page=2